| 2024-10-10 | United States | Settlement | Teva Pharmaceuticals Agrees to Pay $425 Million to Resolve Kickback Allegations U.S. Department of Justice + 1 more reports | $425 Million |
| 2024-10-10 | United States | Settlement | Drug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing U.S. Department of Justice + 2 more reports | $450M |
| 2024 | European Union | Fine / administrative sanction | On October 31, 2024, the European Commission fined Teva €462.6 million "over misuse of the patent system and disparagement to delay [a] rival multiple sclerosis medicine", namely Copaxone (glatiramer Wikipedia: Teva Pharmaceutical Industries（Legal issues） | €462.6 million |
| 2023 | United States | Fine / administrative sanction | In August 2023, Teva admitted to price-fixing charges related to the generic cholesterol drug Pravastatin , and agreed to pay a $225 million fine, after a criminal investigation by the US Department o Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $225 million |
| 2023 | United States | Settlement | Also in August 2023, Teva agreed to a legal settlement with US hospitals over its marketing of opioid products that ultimately raised costs for health providers and contributed to the opioid epidemic Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $126 million |
| 2022 | United States | Settlement | In February 2022, Teva agreed to a $225 million settlement with the state of Texas to end claims that it fueled an opioid epidemic in the state by improperly marketing pain medicine. Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $225 million |
| 2021 | United States | Filed / under investigation | In 2021, New York Attorney General Letitia James filed a lawsuit against Teva and several other opioid manufacturers for their alleged contribution to the opioid epidemic in New York. Wikipedia: Teva Pharmaceutical Industries（Legal issues） | — |
| 2020-08-18 | United States | Filed / under investigation | United States Files False Claims Act Complaint Against Drug Maker Teva Pharmaceuticals U.S. Department of Justice | — |
| 2020-08-18 | United States | Filed / under investigation | United States Files False Claims Act Complaint Against Drug Maker Teva Pharmaceuticals Alleging Illegal Kickbacks U.S. Department of Justice | — |
| 2020 | United States | Settlement | In January 2020, Teva Pharmaceuticals agreed to pay $54 million to settle allegations under the False Claims Act that it violated the Anti-Kickback Statute by funding improper speaking programs to boo Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $54 million |
| 2019 | United States | Judgment for company / dismissed | In January 2019, the Supreme Court of the United States decided for Teva in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc. Wikipedia: Teva Pharmaceutical Industries（Legal issues） | — |
| 2019 | United States | Settlement | On May 11, 2019, Teva Pharmaceuticals USA was one of 19 drug companies sued for price fixing in the United States by 44 states for inflating its prices, sometimes up to 1000%, in an illegal agreement Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $925M / $425M |
| 2019 | United States | Settlement | In May 2019, Teva Pharmaceuticals USA agreed to pay $85 million to the U.S. state of Oklahoma to settle allegations that it had been overprescribing opioids, marketing them as safe, and downplaying th Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $85 million |
| 2019 | United States | Settlement | In July 2019, Teva paid $69 million to settle pay-for-delay claims. Wikipedia: Teva Pharmaceutical Industries（Legal issues） | $69 million |
| 2016-12-22 | United States | Settlement | Teva Pharmaceutical Industries Ltd. Agrees to Pay More Than $283 Million to Resolve Foreign Corrupt Practices Act Charges U.S. Department of Justice + 1 more reports | $283 Million |
| 2016 | United States | Filed / under investigation | In December 2016, the attorneys general of 20 states filed a civil complaint accusing Teva of a coordinated scheme to artificially maintain high prices for a generic antibiotic and diabetes drug. The Wikipedia: Teva Pharmaceutical Industries（Legal issues） | — |
| 2015 | United States | Judgment for company / dismissed | In January 2015, the Supreme Court of the United States decided for Teva on the Copaxone patent in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. Wikipedia: Teva Pharmaceutical Industries（Legal issues） | — |
| 2013-03-14 | United States | Settlement | Teva Pharmaceuticals USA to Pay $2.25 Million Civil Penalty for Air, Water and Hazardous Waste Violations at Missouri Facility U.S. Department of Justice | $2.25 Million |
| 2010 | United States | Settlement | On June 25, 2010, Bayer sued Teva for falsely claiming that Teva's Gianvi was stabilized by betadex as a clathrate , and could consequently be advertised as a generic of Yaz . The settlement resulted Wikipedia: Teva Pharmaceutical Industries（Legal issues） | — |